TABLE 1.
Demographic and biochemical characteristics of patients with celiac disease and control subjects
| Celiac disease (n=31) | Control group (n=32) | p | |
|---|---|---|---|
| Age (years) | 39.4±12.3 | 39.5±4.4 | 0.84 |
| Gender female/male (n/n) | 24/7 | 21/11 | 0.30 |
| Body mass index (kg/m2) | 24.8±4.2 | 24.7±4.3 | 0.97 |
| Systolic BP (mmHg) | 119.7±9.1 | 118.7±8.7 | 0.64 |
| Diastolic BP (mmHg) | 75.5±5.2 | 77.0±5.7 | 0.26 |
| Heart rate (beat/minute) | 72.9±3.7 | 74.1±10.9 | 0.54 |
| Fasting plasma glucose (mg/dl) | 93.1±6.7 | 90.9±6.0 | 0.18 |
| BUN (mg/dl) | 19.9±7.1 | 18.3±4.9 | 0.30 |
| Creatinine (mg/dl) | 0.67±0.19 | 0.64±0.14 | 0.44 |
| Total cholesterol (mg/dl) | 180.4±24.6 | 186.4±31.2 | 0.40 |
| Triglycerides (mg/dl) | 119.1±44.8 | 108.4±51.1 | 0.14 |
| HDL cholesterol (mg/dl) | 42.7±8.8 | 50.0±13.7 | 0.01 |
| LDL cholesterol (mg/dl) | 113.0±20.9 | 115.7±27.3 | 0.65 |
| Non-HDL cholesterol (mg/dl) | 76.3±49.5 | 50.8±57.5 | 0.06 |
| Castelli risk index I | 3.00±1.54 | 2.26±1.54 | 0.06 |
| Castelli risk index II | 2.76±0.83 | 2.46±0.86 | 0.17 |
| Atherogenic index of plasma | 0.98±0.50 | 0.62±0.64 | 0.02 |
| Atherogenic coefficient | 1.20±1.22 | 1.27±1.54 | 0.85 |
| Hemoglobin (mg/dl) | 13.1±1.1 | 14.0±1.1 | 0.22 |
| hsCRP (mg/l) | 3.51±3.18 | 1.92±1.40 | 0.02 |
| ESR (mm/h) | 17.2±12.8 | 9.7±3.1 | 0.01 |
| Disease duration (years) | 5.1±5.4 | n/a | n/a |
| EFT (cm) | 0.49±0.10 | 0.43±0.09 | 0.02 |
| cIMT (cm) | 0.51±0.08 | 0.47±0.08 | 0.10* |
*
Non-parametric test (Mann–Whitney U). BP: Blood pressure; BUN: Blood urea nitrogen; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; hsCRP: High-sensitivity C-reactive protein; ESR: Erythrocyte sedimentation rate; EFT: Epicardial fat thickness; cIMT: Carotid intima–media thickness; atherogenic coefficient: non-HDL-c/HDL-c; atherogenic index of plasma: log TG/HDL-c; Castelli risk index I: TC/HDL-c; Castelli risk index II: LDLc/HDL-c; non-HDL-c: TC-HDL-c.